mizoribine has been researched along with Ureteral Obstruction in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Endo, A; Fujinaga, S; Hirano, D; Murano, Y; Ohtomo, Y; Sakuraya, K; Shimizu, T; Someya, T | 1 |
Kawamura, T; Sakai, T; Shirasawa, T | 1 |
Kai, K; Kobayashi, Y; Mitarai, T; Ogawa, S; Sato, N; Shiraiwa, K; Utsunomiya, Y; Watanabe, A; Yamagishi-Imai, H | 1 |
3 other study(ies) available for mizoribine and Ureteral Obstruction
Article | Year |
---|---|
The synergistic effect of mizoribine and a direct renin inhibitor, aliskiren, on unilateral ureteral obstruction induced renal fibrosis in rats.
Topics: Amides; Animals; Drug Synergism; Drug Therapy, Combination; Fibrosis; Fumarates; Kidney; Male; Rats; Rats, Sprague-Dawley; Renin; Ribonucleosides; Transforming Growth Factor beta1; Ureteral Obstruction | 2014 |
Mizoribine improves renal tubulointerstitial fibrosis in unilateral ureteral obstruction (UUO)-treated rat by inhibiting the infiltration of macrophages and the expression of alpha-smooth muscle actin.
Topics: Actins; Animals; Cell Movement; Female; Fibrosis; Immunosuppressive Agents; Kidney Diseases; Kidney Tubules; Macrophages; Muscle, Smooth; Rats; Rats, Sprague-Dawley; Ribonucleosides; Ureteral Obstruction | 1997 |
Mizoribine ameliorates the tubulointerstitial fibrosis of obstructive nephropathy.
Topics: Animals; Fibrosis; Immunosuppressive Agents; Kidney Tubules, Proximal; Macrophages; Male; Nephritis, Interstitial; Osteopontin; Rats; Rats, Wistar; Ribonucleosides; Sialoglycoproteins; T-Lymphocytes; Ureteral Obstruction | 2001 |